# Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding

> **NCT00539877** · PHASE1 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** irinotecan

## Key facts

- **NCT ID:** NCT00539877
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2006-12
- **Final completion:** 2007-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2010-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539877, "Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00539877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*